rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM

Carroll, P. V., Umpleby, M., Ward, G. S., Imuere, S., Alexander, E., Dunger, D., … Russell-Jones, D. L. (1997). rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM. Diabetes, 46(9), 1453–1458. https://doi.org/10.2337/diabetes.46.9.1453